未登录

H

Huojun Zhang

Naval Medical University

H指数:15

被引数:627

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART)

中央提升式烧蚀放射疗法治疗实体瘤：一项单臂、II期试验（CBART）的研究方案

Technology in Cancer Research & Treatment

IF2.8

2025-06-120

OA

Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer

转移性胰腺癌患者的原发性肿瘤和寡转移的立体定向放射治疗与单独的原发性肿瘤治疗

RADIATION ONCOLOGY

IF3.2

2024-08-192

OAAI

Immune profiling of pancreatic cancer for radiotherapy with immunotherapy and targeted therapy: Biomarker analysis of a randomized phase 2 trial

RADIOTHERAPY AND ONCOLOGY

IF5.3

2024-01-011

PRE

Using optimal controlled singlet spin order to accurately target molecular signal in MRI and MRS

SCIENTIFIC REPORTS

IF3.9

2023-02-071

OAAI

Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration

FRONTIERS IN ONCOLOGY

IF3.3

2023-01-301

OAAI

Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer

IF3.4

2023-01-210

OAAI

Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial

ECLINICALMEDICINE

IF10

2023-01-017

OAAI

Distinguishing glutamate and glutamine in in vivo 1H MRS based on nuclear spin singlet order filtering

MAGNETIC RESONANCE IN MEDICINE

IF3

2022-12-268

PRE

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases

FRONTIERS IN ONCOLOGY

IF3.3

2021-11-023

OAAI

Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trial

RADIOTHERAPY AND ONCOLOGY

IF5.3

2021-09-017

PRE

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2021-06-084

OAAI

Nomogram for prediction of fatal outcome in patients with severe COVID-19: a multicenter study

列线图预测严重新型冠状病毒肺炎患者的致命结局: 一项多中心研究

MILITARY MEDICAL RESEARCH

IF22.9

2021-03-1713

OAAI

Radiosensitization of human pancreatic cancer by piperlongumine analogues

CHINESE CHEMICAL LETTERS

IF8.9

2021-03-0125

PREAI

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2020-12-1416

OAAI

Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency

JOURNAL OF CONTROLLED RELEASE

IF11.5

2020-08-0125

PREAI

Prognostic value of 18F-FDG PET/CT metabolic parameters in patients with locally advanced pancreatic Cancer treated with stereotactic body radiation therapy

IF3.5

2020-03-108

OAAI

Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications

CANCER BIOLOGY & MEDICINE

IF8.4

2020-01-011

OAAI

Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2019-05-0162

PREAI

Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1)

RADIATION ONCOLOGY

IF3.2

2019-03-2714

OAAI

Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score)

RADIOTHERAPY AND ONCOLOGY

IF5.3

2018-11-0116

PREAI